Pharmacological separation of early afterdepolarizations from arrhythmogenic substrate in ΔKPQ Scn5a murine hearts modelling human long QT 3 syndrome

Acta Physiologica

Volumn 192, Issue 4, 2008, Pages 505-517

  Thomas, G ^a   Killeen, M J ^a   Grace, A A ^a   Huang, C L H ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Arrhythmogenesis; Long QT3 syndrome; Propranolol

Indexed keywords

PROPRANOLOL;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARRHYTHMOGENESIS; ARTICLE; ELECTROSTIMULATION; ENDOCARDIUM; EPICARDIUM; EXTRASYSTOLE; GENE; HEART DEPOLARIZATION; HEART MUSCLE POTENTIAL; HEART PERFUSION; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME; MOUSE; NONHUMAN; PRIORITY JOURNAL; REENTRY ARRHYTHMIA; SCN5A GENE; WILD TYPE;

ACTION POTENTIALS; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIAC ELECTROPHYSIOLOGY; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HUMANS; LONG QT SYNDROME; MICE; PROPRANOLOL; SODIUM CHANNELS;

EID: 40049087004     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2007.01770.x     Document Type: Article

References (55)

1. Aiba, T., Shimizu, W., Inagaki, M., Noda, T., Miyoshi, S., Ding, W.G. et al. 2005. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil. J Am Coll Cardiol 45, 300 307.
2. Antzelevitch, C. Yan, G.X. 2000. Cellular and ionic mechanisms responsible for the Brugada syndrome. J Electrocardiol 33 (Suppl. 33 39.
3. Antzelevitch, C., Shimizu, W., Yan, G.X. Sicouri, S. 1998. Cellular basis for QT dispersion. J Electrocardiol 30 (Suppl. 168 175.
4. Anumonwo, J.M., Tallini, Y.N., Vetter, F.J. Jalife, J. 2001. Action potential characteristics and arrhythmogenic properties of the cardiac conduction system of the murine heart. Circ Res 89, 329 335.
5. Baker, L.C., London, B., Choi, B.R., Koren, G. Salama, G. 2000. Enhanced dispersion of repolarization and refractoriness in transgenic mouse hearts promotes reentrant ventricular tachycardia. Circ Res 86, 396 407.
6. Balasubramaniam, R., Grace, A.A., Saumarez, R.C., Vandenberg, J.I. Huang, C.L. 2003. Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1. J Physiol 552, 535 546.
7. van den Berg, M.P., Wilde, A.A., Viersma, T.J.W., Brouwer, J., Haaksma, J., van der Hout, A.H. et al. 2001. Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome. J Cardiovasc Electrophysiol 12, 630 636.
8. Cosio, F.G., Goicolea, A., Lopez Gil, M., Kallmeyer, C. Barroso, J.L. 1991. Suppression of Torsades de Pointes with verapamil in patients with atrio-ventricular block. Eur Heart J 12, 635 638.
9. Damiano, B.P. Rosen, M.R. 1984. Effects of pacing on triggered activity induced by early afterdepolarizations. Circulation 69, 1013 1025.
10. Davis, L.D. Temte, J.V. 1968. Effects of propranolol on the transmembrane potentials of ventricular muscle and Purkinje fibers of the dog. Circ Res 22, 661 677.
11. Dilly, K.W., Rossow, C.F., Votaw, V.S., Meabon, J.S., Cabarrus, J.L. Santana, L.F. 2006. Mechanisms underlying variations in excitation-contraction coupling across the mouse left ventricular free wall. J Physiol 572, 227 241.
12. Duff, H.J., Roden, D.M., Brorson, L., Wood, A.J., Dawson, A.K., Primm, R.K. et al. 1983. Electrophysiologic actions of high plasma concentrations of propranolol in human subjects. J Am Coll Cardiol 2, 1134 1140.
13. Eckardt, L., Haverkamp, W., Borggrefe, M. Breithardt, G. 1998. Experimental models of torsade de pointes. Cardiovasc Res 39, 178 193.
14. Fabritz, L., Kirchhof, P., Franz, M.R., Eckardt, L., Monnig, G., Milberg, P. et al. 2003a. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia. Basic Res Cardiol 98, 25 32.
15. Fabritz, L., Kirchhof, P., Franz, M.R., Nuyens, D., Rossenbacker, T., Ottenhof, A. et al. 2003b. Effect of pacing and mexiletine on dispersion of repolarisation and arrhythmias in DeltaKPQ SCN5A (long QT3) mice. Cardiovasc Res 57, 1085 1093.
16. Fabritz, L., Emmerich, M., Fortmueller, L., Franz, M.R., Breithardt, G., Carmeliet, P. et al. 2005. Aggravation of bradycardia by propranolol in deltaKPQ SCN5A (Long QT3) mice. Eur Heart J 26 (Abstract Supplement S299.
17. Head, C.E., Balasubramaniam, R., Thomas, G., Goddard, C.A., Lei, M., Colledge, W.H. 2005. Paced electrogram fractionation analysis of arrhythmogenic tendency in KPQ Scn5a mice. J Cardiovasc Electrophysiol 16, 1329 1340.
18. Huelsing, D.J., Spitzer, K.W. Pollard, A.E. 2000. Electrotonic suppression of early afterdepolarizations in isolated rabbit Purkinje myocytes. Am J Physiol Heart Circ Physiol 279, H250 H259.
19. 2+ current. Circ Res 64, 977 990.
20. Kannel, W.B., Cupples, L.A. D'Agostino, R.B. 1987. Sudden death risk in overt coronary heart disease: the Framingham Study. Am Heart J 113, 799 804.
21. Killeen, M.J. Sabir, I.N. 2007. Repolarization gradients and arrhythmogenicity in the murine heart. J Physiol 583, 419 420.
22. Killeen, M.J., Thomas, G., Gurung, I.S. et al. 2007a. Arrhythmogenic mechanisms in the isolated perfused hypokalaemic murine heart. Acta Physiol (Oxf) 189, 33 46.
23. Killeen, M.J., Gurung, I.S., Thomas, G., Stokoe, K.S., Grace, A.A. Huang, C.L. 2007b. Separation of early afterdepolarizations from arrhythmogenic substrate in the isolated perfused hypokalaemic murine heart through modifiers of calcium homeostasis. Acta Physiol (Oxf) 191, 43 58.
24. Knollmann, B.C., Katchman, A.N. Franz, M.R. 2001. Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 12, 1286 1294.
25. Krishnan, S.C. Antzelevitch, C. 1991. Sodium channel block produces opposite electrophysiological effects in canine ventricular epicardium and endocardium. Circ Res 69, 277 291.
26. London, B., Baker, L.C., Petkova-Kirova, P., Nerbonne, J.M., Choi, B.R. Salama, G. 2007. Dispersion of repolarization and refractoriness are determinats of arrhythmia phenotype in transgenic mice with long QT. J Physiol 578, 115 129.
27. Lukas, A. Antzelevitch, C. 1993. Differences in the electrophysiological response of canine ventricular epicardium and endocardium to ischemia. Role of the transient outward current. Circulation 88, 2903 2915.
28. Maguire, C.T., Wakimoto, H., Patel, V.V., Hammer, P.E., Gauvreau, K. Berul, C.I. 2003. Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies. Physiol Genomics 15, 84 91.
29. Matthews, J.C. Baker, J.K. 1982. Effects of propranolol and a number of its analogues on sodium channels. Biochem Pharmacol 31, 1681 1685.
30. Milberg, P. Eckardt, L. 2005. Transmural dispersion in LQT3 and arrhythmogenesis. Cardiovasc Res 68, 338 339.
31. Moss, A.J. 1998. Management of patients with the hereditary long QT syndrome. J Cardiovasc Electrophysiol 9, 668 674.
32. Moss, A.J., Zareba, W., Hall, W.J., Schwartz, P.J., Crampton, R.S., Benhorin, J. et al. 2000. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 101, 616 623.
33. NICE 2000. Guidance on the Use of Implantable Cardioverter Defibrillators for Arrhythmias. Department of Health, London.
34. Nuyens, D., Stengl, M., Dugarmaa, S., Rossenbacker, T., Compernolle, V., Rudy, Y. et al. 2001. Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome. Nat Med 7, 1021 1027.
35. Priori, S.G., Napolitano, C., Schwartz, P.J., Grillo, M., Bloise, R., Ronchetti, E. et al. 2004. Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. JAMA 292, 1341 1344.
36. Pruett, J.K., Walle, T. Walle, U.K. 1980. Propranolol effects on membrane repolarization time in isolated canine Purkinje fibers: threshold tissue content and the influence of exposure time. J Pharmacol Exp Ther 215, 539 543.
37. Rauls, D.O. Baker, J.K. 1979. Relationship of nonspecific antiarrhythmic and negative inotropic activity with physicochemical parameters of propranolol analogues. J Med Chem 22, 81 86.
38. Restivo, M., Caref, E.B., Kozhevnikov, D.O. El-Sherif, N. 2004. Spatial dispersion of repolarization is a key factor in the arrhythmogenicity of long QT syndrome. J Cardiovasc Electrophysiol 15, 323 331.
39. Sabir, I.N., Fraser, J.A., Cass, T.R., Grace, A.A. Huang, C.L. 2007. A quantitative analysis of the effect of cycle length on arrhythmogenicity in hypokalaemic Langendorff-perfused murine hearts. Pflugers Arch 454, 925 936.
40. Saumarez, R.C., Camm, A.J., Panagos, A., Gill, J.S., Stewart, J.T., de Belder, M.A. et al. 1992. Ventricular fibrillation in hypertrophic cardiomyopathy is associated with increased fractionation of paced right ventricular electrograms. Circulation 86, 467 474.
41. Schwartz, P.J., Priori, S.G., Spazzolini, C., Moss, A.J., Vincent, G.M., Napolitano, C. et al. 2001. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 103, 89 95.
42. Shimizu, W. Antzelevitch, C. 2000. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 35, 778 786.
43. Simaan, J. Fawaz, G. 1971. The effect of endogenous catecholamines and norepinephrine administration on the performance of the isolated canine heart. Naunyn Schmiedebergs Arch Pharmakol 268, 17 26.
44. Stokoe, K.S., Thomas, G., Goddard, C.A., Colledge, W.H., Grace, A.A. Huang, C.L. 2007. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/delta murine hearts modelling long QT syndrome 3. J Physiol 578, 69 84.
45. 2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3. J Physiol 578, 85 97.
46. Thomas, G., Killeen, M.J., Gurung, I.S., Hakim, P., Balasubramaniam, R., Goddard, C.A. et al. 2007b. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5. J Physiol 578, 99 114.
47. Tian, X.L., Cheng, Y., Zhang, T., Liao, M.L., Yong, S.L. Wang, Q.K. 2007. Optical mapping of ventricular arrhythmias in LQTS mice with SCN5A mutation N1325S. Biochem Biophys Res Commun 352, 879 883.
48. Volders, P.G., Vos, M.A., Szabo, B., Sipido, K.R., de Groot, S.H., Gorgels, A.P. et al. 2000. Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes: time to revise current concepts. Cardiovasc Res 46, 376 392.
49. Wang, Q., Shen, J., Li, Z., Timothy, K., Vincent, G.M., Priori, S.G. et al. 1995a. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 4, 1603 1607.
50. Wang, Q., Shen, J., Splawski, I., Atkinson, D., Li, Z., Robinson, J.L. et al. 1995b. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 80, 805 811.
51. Weselcouch, E.O., Baird, A.J., Sleph, P.G., Dzwonczyk, S., Murray, H.N. Grover, G.J. 1995. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 29, 126 132.
52. Willich, S.N., Levy, D., Rocco, M.B., Tofler, G.H., Stone, P.H. Muller, J.E. 1987. Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population. Am J Cardiol 60, 801 806.
53. Woosley, R.L., Kornhauser, D., Smith, R., Reele, S., Higgins, S.B., Nies, A.S. 1979. Suppression of chronic ventricular arrhythmias with propranolol. Circulation 60, 819 827.
54. Yan, G.X., Wu, Y., Liu, T., Wang, J., Marinchak, R.A. Kowey, P.R. 2001. Phase 2 early afterdepolarization as a trigger of polymorphic ventricular tachycardia in acquired long-QT syndrome: direct evidence from intracellular recordings in the intact left ventricular wall. Circulation 103, 2851 2856.
55. Zeng, J. Rudy, Y. 1995. Early afterdepolarizations in cardiac myocytes: mechanism and rate dependence. Biophys J 68, 949 964.